California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on September 8, 2026

12 hours ago

RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026

Indeterminate GlobeNewswire

12 hours ago

Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1

Indeterminate GlobeNewswire

12 hours ago

Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study

Indeterminate GlobeNewswire

13 hours ago

Orikine appoints new CEO and Leadership Team to advance ORK1 in Autoimmune Disease

Indeterminate GlobeNewswire

14 hours ago

Von intelligenter Massage bis hin zu proaktiver Wellness: SKG erweitert sein Portfolio tragbarer Gesundheitsgeräte auf der IFA 2026

Indeterminate GlobeNewswire

14 hours ago

Du massage intelligent au bien-être proactif : SKG élargit sa gamme de dispositifs de santé portables à l’occasion de l’IFA 2026

Indeterminate GlobeNewswire

14 hours ago

From Smart Massage to Proactive Wellness: SKG Expands Its Wearable Health Portfolio at IFA 2026

Indeterminate GlobeNewswire

15 hours ago

New Multi-Site Validation Study Published by Panakeia Reinforces Scalability of AI Multi-Omics Platform

Indeterminate GlobeNewswire

15 hours ago

Upstream Bio Presents Results from the Phase 2 VALIANT Trial of Verekitug for the Treatment of Severe Asthma in Oral Presentation at ERS Congress 2026

Indeterminate GlobeNewswire

15 hours ago

PannTheraPi Receives ANSM Approval to Advance PTI5803 into Phase 2a in Focal Cortical Dysplasia

Indeterminate GlobeNewswire

15 hours ago

Cytospire Therapeutics Appoints Highly Experienced Immuno-Oncology Leader, Sumeet Ambarkhane, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

15 hours ago

PannTheraPi obtient l'approbation de l’ANSM pour l’entrée en Phase 2a de PTI5803 dans la dysplasie corticale focale

Indeterminate GlobeNewswire

16 hours ago

Greywolf Therapeutics doses first participants with axSpA in novel ERAP1 inhibitor trial

Indeterminate GlobeNewswire

16 hours ago

Rapid Nutrition Reports 227.5% H1 Revenue Growth as Group Enters Transformational Second Half

Indeterminate GlobeNewswire

Sep. 8, 2026

Global Healthcare Leaders Foundation Celebrates 16 Healthcare Leaders and Advances New Era of Leadership, Innovation and Global Connection

Indeterminate GlobeNewswire